What is a collaborator?
A collaborator is an agency that supports the goals of the grant by contributing materials, services, and other assets to the grant program. The use of collaborators allows for more efficient use of local resources and encourages cooperation among diverse organizations, thereby strengthening the quality and variety of services communities offer. Q: What is a “site?” A: The definition of a site varies with the two grant programs: • ESFL: A site is the location at which the program is administered most often the location of the lead agency. As such, there is only one site. • 21stCCLC: A site is a location at which program activities are held. 21stCCLC programs may have multiple sites. Q: What is an “entity? A: An entity is an organization or institution that plays a role in an ESFL or 21stCCLC grant program. For example, an entity may be a school district; a school, college, or university; a nonprofit organization; or a for-profit organization. Within the grant program, it may fun
A collaborator is a major user who is expected to contribute to the overall intellectual and scientific direction of the resource’s activities and research programs. Collaborators must be qualified to undertake research independently. Collaborators are not eligible to hold NSERC grants. Examples of collaborators are government scientists, company personnel or research scientists from other countries. There is no typical number of collaborators and no limit on this number. Collaborators may be listed within the maximum number of free-form pages allowed to describe the proposal and address the selection criteria in Form 101.
Related Questions
- My collaborator and/or my mentor also wish to come to the conference. Do we all need to complete the online application and confirmation/pre-registration forms jointly or separately?
- One must first consider the following: Is the Grantee or Collaborator licensing the CIRM-funded Invention or CIRM-Funded Technology, or is it self-commercializing it?
- Are the license revenue sharing provisions applicable to a Grantee or Collaborator proportional to CIRM’s investment in an invention?